Evidence map›Paper›PMID 41179271›Full record

ArticleJCEM case reports2025

Pituitary Xanthogranuloma Causing Sellar Mass in 2 Children With Hypopituitarism and Elevated Inflammatory Markers.

Madalin Berra, Laurel Gordon, Nikta Forghani

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Madalin BerraUniversity of California Irvine, Orange, CA 92868, USA.ORCID https://orcid.org/0009-0003-6472-9546
Laurel GordonChildren's Hospital of Los Angeles, Los Angeles, CA 90027, USA.
Nikta ForghaniChildren's Hospital of Orange County, Orange, CA 92868, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pituitary xanthogranulomas represent a rare group of inflammatory pituitary masses. The prevalence of these lesions is not clearly defined. These lesions, also known as cholesterol granulomas, are diagnosed on histopathological findings including cholesterol clefts, hemosiderin deposits, foamy macrophages, and necrosis. They often present with pituitary hormone deficiencies and have a low recurrence rate following gross total resection. We describe 2 patients presenting with headaches, polyuria, polydipsia, and elevated erythrocyte sedimentation rate. One patient had a history of Rathke cleft cyst (RCC). Magnetic resonance imaging identified sellar masses, and they were subsequently diagnosed with varying degrees of pituitary hormone deficiencies preoperatively. They underwent transsphenoidal mass resection with pathology showing xanthogranuloma. Postoperatively they have panhypopituitarism including arginine vasopressin deficiency and no recurrence of the lesion. Inflammatory causes of pituitary lesions should remain on the differential, especially in patients with a history of RCC. More research is needed to identify the prevalence of xanthogranulomatous pituitary lesions and better understand the pathophysiology of their formation. The finding of elevated inflammatory markers, not usually seen in other pituitary masses or previously documented in the literature in cases of xanthogranulomatous pituitary lesions, could reflect a clinical clue when evaluating patients with pituitary lesions.

Indexed as

cholesterol granulomahypopituitarismsellar massxanthogranuloma

Identifiers

PMID41179271
PMCPMC12576541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.